Associated Papers
HIV-1 protease mutations and protease inhibitor cross-resistance.
Rhee SY et al.
Antimicrobial Agents and Chemotherapy, 2010
Identification of new genotypic cut-off levels to predict the efficacy of lopinavir/ritonavir and darunavir/ritonavir in the TITAN trial.
Hill A et al.
Hiv Medicine, 2009
Molecular characterization of clinical isolates of human immunodeficiency virus resistant to the protease inhibitor darunavir.
Sasková KG et al.
Journal of Virology, 2009
Select a paper to view details